Immunohistochemistry analysis of clinical samples from 100 HCC patients has shown that EGFR expression is elevated in HCC lesions but not in adjacent nontransformed hepatic cells in 53 cases and ErbB3 overexpression in HCC lesions is observed in 64 cases. This evidence concerns the gene ERBB3 and hepatocellular carcinoma.